XML 84 R71.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Segments and Disaggregated Revenue (Details) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Segments and Disaggregated Revenue      
Revenue $ 1,017,931 $ 5,503,935  
Cost of revenue 644,983 5,573,407  
Operating expenses 4,405,407 3,190,597  
Operating loss (4,032,459) (3,260,069)  
Other income (expense) (1,224,569) (259,371)  
Loss before income taxes (5,257,028) (3,519,440)  
Common stock deemed dividend (670,881)  
Net income attributable to non-controlling interest 1,257,745  
Net loss attributable to common stockholders (4,670,164) (3,519,440)  
Total assets 19,955,096   $ 17,211,275
Operating Segments [Member]      
Segments and Disaggregated Revenue      
Revenue 1,017,931 5,503,935  
Cost of revenue 644,983 5,573,407  
Operating expenses 4,405,407 3,190,597  
Operating loss (4,032,459) (3,260,069)  
Other income (expense) (1,224,569) (259,371)  
Loss before income taxes (5,257,028) (3,519,440)  
Common stock deemed dividend (670,881)    
Net income attributable to non-controlling interest 1,257,745  
Net loss attributable to common stockholders (4,670,164) (3,519,440)  
Total assets 19,955,094 28,440,775  
Depreciation and amortization 76,387 148,508  
Capital expenditures 31,841 531,083  
Operating Segments [Member] | Construction [Member]      
Segments and Disaggregated Revenue      
Revenue 968,115 5,503,935  
Cost of revenue 644,983 5,573,407  
Operating expenses 533 118,560  
Operating loss 322,599 (188,032)  
Other income (expense) (49,953) 18,564  
Loss before income taxes 272,646 (169,468)  
Common stock deemed dividend    
Net income attributable to non-controlling interest  
Net loss attributable to common stockholders 272,646 (169,468)  
Total assets 5,415,394 10,458,066  
Depreciation and amortization 74,707 148,508  
Capital expenditures 531,083  
Operating Segments [Member] | Medical [Member]      
Segments and Disaggregated Revenue      
Revenue  
Cost of revenue  
Operating expenses 35,884 897  
Operating loss (35,884) (897)  
Other income (expense)  
Loss before income taxes (35,884) (897)  
Common stock deemed dividend    
Net income attributable to non-controlling interest  
Net loss attributable to common stockholders (35,884) (897)  
Total assets 51,481 4,581  
Depreciation and amortization  
Capital expenditures  
Operating Segments [Member] | Development [Member]      
Segments and Disaggregated Revenue      
Revenue 49,816  
Cost of revenue  
Operating expenses 2,551,492 720,913  
Operating loss (2,501,676) (720,913)  
Other income (expense) (565,995) (287,297)  
Loss before income taxes (3,067,671) (1,008,210)  
Common stock deemed dividend    
Net income attributable to non-controlling interest 1,257,745  
Net loss attributable to common stockholders (1,809,926) (1,008,210)  
Total assets 11,810,852 11,369,614  
Depreciation and amortization  
Capital expenditures 31,841  
Operating Segments [Member] | Corporate and support [Member]      
Segments and Disaggregated Revenue      
Revenue  
Cost of revenue  
Operating expenses 1,817,498 2,350,227  
Operating loss (1,817,498) (2,350,227)  
Other income (expense) (608,621) 9,362  
Loss before income taxes (2,426,119) (2,340,865)  
Common stock deemed dividend (670,881)    
Net income attributable to non-controlling interest  
Net loss attributable to common stockholders (3,097,000) (2,340,865)  
Total assets 2,677,367 6,608,514  
Depreciation and amortization 1,680  
Capital expenditures  
Intersegment Eliminations [Member]      
Segments and Disaggregated Revenue      
Revenue    
Intersegment Eliminations [Member] | Construction [Member]      
Segments and Disaggregated Revenue      
Revenue    
Intersegment Eliminations [Member] | Medical [Member]      
Segments and Disaggregated Revenue      
Revenue    
Intersegment Eliminations [Member] | Development [Member]      
Segments and Disaggregated Revenue      
Revenue    
Intersegment Eliminations [Member] | Corporate and support [Member]      
Segments and Disaggregated Revenue      
Revenue